Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10385324rdf:typepubmed:Citationlld:pubmed
pubmed-article:10385324lifeskim:mentionsumls-concept:C0035736lld:lifeskim
pubmed-article:10385324lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:10385324lifeskim:mentionsumls-concept:C0035681lld:lifeskim
pubmed-article:10385324lifeskim:mentionsumls-concept:C0079925lld:lifeskim
pubmed-article:10385324lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:10385324lifeskim:mentionsumls-concept:C2076600lld:lifeskim
pubmed-article:10385324lifeskim:mentionsumls-concept:C1335440lld:lifeskim
pubmed-article:10385324lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:10385324lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:10385324lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:10385324lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:10385324pubmed:issue6lld:pubmed
pubmed-article:10385324pubmed:dateCreated1999-7-15lld:pubmed
pubmed-article:10385324pubmed:abstractTextWe have investigated the ability of antisense phosphorothioate oligonucleotides to enhance the survival of mice infected with influenza A virus. The oligonucleotides were complementary to sequences surrounding the translation initiation codons of the viral PB2 or PA genes (PB2-as or PA-as, respectively) of the influenza A virus RNA polymerases. Intravenous administration of PB2-as in a complex with a cationic liposome, Tfx-10, significantly prolonged the mean survival time in days and increased overall survival rates of mice infected with the influenza A virus. Liposomally encapsulated PB2-as inhibited viral growth in lung tissues and reduced pulmonary consolidations. Liposomally encapsulated PB2-as could be an effective therapeutic agent against influenza A virus.lld:pubmed
pubmed-article:10385324pubmed:languageenglld:pubmed
pubmed-article:10385324pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10385324pubmed:citationSubsetIMlld:pubmed
pubmed-article:10385324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10385324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10385324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10385324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10385324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10385324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10385324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10385324pubmed:statusMEDLINElld:pubmed
pubmed-article:10385324pubmed:monthJunlld:pubmed
pubmed-article:10385324pubmed:issn1087-0156lld:pubmed
pubmed-article:10385324pubmed:authorpubmed-author:AbeTTlld:pubmed
pubmed-article:10385324pubmed:authorpubmed-author:FujiwaraMMlld:pubmed
pubmed-article:10385324pubmed:authorpubmed-author:YokotaTTlld:pubmed
pubmed-article:10385324pubmed:authorpubmed-author:ShigetaSSlld:pubmed
pubmed-article:10385324pubmed:authorpubmed-author:HattaTTlld:pubmed
pubmed-article:10385324pubmed:authorpubmed-author:MizutaTTlld:pubmed
pubmed-article:10385324pubmed:authorpubmed-author:TakakuHHlld:pubmed
pubmed-article:10385324pubmed:authorpubmed-author:Miyano-Kurosa...lld:pubmed
pubmed-article:10385324pubmed:issnTypePrintlld:pubmed
pubmed-article:10385324pubmed:volume17lld:pubmed
pubmed-article:10385324pubmed:ownerNLMlld:pubmed
pubmed-article:10385324pubmed:authorsCompleteYlld:pubmed
pubmed-article:10385324pubmed:pagination583-7lld:pubmed
pubmed-article:10385324pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:meshHeadingpubmed-meshheading:10385324...lld:pubmed
pubmed-article:10385324pubmed:year1999lld:pubmed
pubmed-article:10385324pubmed:articleTitleAntisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A.lld:pubmed
pubmed-article:10385324pubmed:affiliationRational Drug Design Laboratories, Makutsawa-Machi, Fukushima, Japan.lld:pubmed
pubmed-article:10385324pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10385324pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10385324lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10385324lld:pubmed